Talaris Therapeutics Inc. (TALS) NASDAQ

$12.38 -0.58 (-4.47%)

Market Cap: $535.96M

As of 12/01/21 04:00 PM EST. Market closed.

(TALS)

Talaris Therapeutics Inc. (TALS) NASDAQ

$12.38 -0.58 (-4.47%)

Market Cap: $535.96M

As of 12/01/21 04:00 PM EST. Market closed.

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Full Time Employees
82
URL
Address
.
KEY STATS
Open
$13.59
Previous Close
$12.96
Days Range
$12.33 - $13.64
52 week range
$11.30 - $19.82
Volume
44,874
Avg. Volume (30 days)
84,670
Market Cap
$535.96M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
41,354,643
Open
$13.59
Previous Close
$12.96
Days Range
$12.33 - $13.64
52 week range
$11.30 - $19.82
Volume
44,874
Avg. Volume (30 days)
84,670
Market Cap
$535.96M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
41,354,643

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR TALARIS THERAPEUTICS INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Clarus Lifesciences III, L.P. 10% Owner May 11, 2021 Buy $17.00 30,000 510,000 4,875,730 May 14, 2021, 06:15 AM
Clarus Defined Exit I, L.P. 10% Owner May 11, 2021 Buy $17.00 30,000 510,000 4,875,730 May 13, 2021, 09:59 PM
Agarwala Sandip Director May 11, 2021 Buy $17.00 235,000 3,995,000 3,220,775 May 11, 2021, 08:29 PM
Buy Sale Option Exercise
Owner Relationship Date Value($)
Clarus Lifesciences III, L.P. 10% Owner 05/11/2021 510,000
Clarus Defined Exit I, L.P. 10% Owner 05/11/2021 510,000
Agarwala Sandip Director 05/11/2021 3,995,000